IMMPImmutep Limited

IMMP Stock Price, Valuation & Chart | Immutep Limited

Compare

$0.380+0.01 (+3.15%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology IMMP intrinsic value IMMP calculated fair value vs price

Overview Financials Dividends Ratios

IMMP Historical price chart

IMMP Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization56.43M

PE Ratio-0.98

EPS-0.39

Trading Volume115.76K

Today's High/Low0.39/0.37

Dividend Yield0.00

52 Week High/Low3.53/0.29

Shares Outstanding147.37M

IMMP Financial Statement

IMMP Analyst ratings

IMMP Analysis & performance metrics

IMMP Company profile

Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical product candidates. The company develops immunotherapeutic products for…

Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical product candidates. The company develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. Its lead product candidate is eftilagimod alpha (efti or IMP321), a recombinant protein that is in Phase IIb clinical trial as a chemoimmunotherapy combination for…

IMMP Management team

Name

Position

Christian Mueller BBA, MSc.

Chief Development Officer

Deanne Miller LLBCOO

Chief Operating Officer, General Counsel & Joint Company Secretary

Frederic Triebel M.D., Ph.D.CTO

Chief Scientific Officer & Executive Director

Stephan Winckels M.D., Ph.D.

Acting Chief Medical Officer

Indira Naidu

Joint Company Secretary

Marc VoigtCEO

Chief Executive Officer, MD, Chief Financial Officer, Chief Business Officer & Executive Director

Name

Position

Christian Mueller BBA, MSc.

Chief Development Officer

Deanne Miller LLBCOO

Chief Operating Officer, General Counsel & Joint Company Secretary

Frederic Triebel M.D., Ph.D.CTO

Chief Scientific Officer & Executive Director

Stephan Winckels M.D., Ph.D.

Acting Chief Medical Officer

Indira Naidu

Joint Company Secretary

Marc VoigtCEO

Chief Executive Officer, MD, Chief Financial Officer, Chief Business Officer & Executive Director

Management Team

Christian Mueller BBA, MSc.

Chief Development Officer

Deanne Miller LLBCOO

Chief Operating Officer, General Counsel & Joint Company Secretary

Frederic Triebel M.D., Ph.D.CTO

Chief Scientific Officer & Executive Director

Stephan Winckels M.D., Ph.D.

Acting Chief Medical Officer

Indira Naidu

Joint Company Secretary

Marc VoigtCEO

Chief Executive Officer, MD, Chief Financial Officer, Chief Business Officer & Executive Director

Management

Christian Mueller BBA, MSc.

Chief Development Officer

Deanne Miller LLBCOO

Chief Operating Officer, General Counsel & Joint Company Secretary

Frederic Triebel M.D., Ph.D.CTO

Chief Scientific Officer & Executive Director

Stephan Winckels M.D., Ph.D.

Acting Chief Medical Officer

Indira Naidu

Joint Company Secretary

Marc VoigtCEO

Chief Executive Officer, MD, Chief Financial Officer, Chief Business Officer & Executive Director

Total 6 executives

IMMP Frequently asked questions

What is Immutep Limited (IMMP) Stock Price?

Current stock price of Immutep Limited (IMMP) stock is $0.380. The stock price is +3.15% higher in the session. The intraday range can be seen from this page. Volume of Immutep Limited (IMMP) stock is 115.76K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Immutep Limited (IMMP) stock price going up or down today?

The stock price of Immutep Limited (IMMP) can change with earnings, company news, and overall market sentiment. Immutep Limited operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Immutep Limited stock expensive at its current price?

Whether Immutep Limited looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for IMMP on this page is -0.98. EPS on this page is -0.39. Compare those figures with peers and growth expectations before deciding if the current Immutep Limited price is justified.

How has the stock price of Immutep Limited (IMMP) performed historically?

Historical performance for Immutep Limited (IMMP) is shown on the price chart on this page. Review multi-period moves alongside volume to see how IMMP reacted to past earnings and market events.

Should I buy Immutep Limited (IMMP) stock, at this price?

Buying Immutep Limited (IMMP) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.